- Home
- MUX vs ALDX Comparison
MUX vs ALDX Comparison
Compare MUX & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MUX
- ALDX
- Stock Information
- Founded
- MUX 1979
- ALDX 2004
- Country
- MUX Canada
- ALDX United States
- Employees
- MUX N/A
- ALDX N/A
- Industry
- MUX Precious Metals
- ALDX Biotechnology: Pharmaceutical Preparations
- Sector
- MUX Basic Materials
- ALDX Health Care
- Exchange
- MUX Nasdaq
- ALDX Nasdaq
- Market Cap
- MUX 435.3M
- ALDX 133.7M
- IPO Year
- MUX N/A
- ALDX 2014
- Fundamental
- Price
- MUX $7.40
- ALDX $2.16
- Analyst Decision
- MUX Strong Buy
- ALDX Strong Buy
- Analyst Count
- MUX 2
- ALDX 2
- Target Price
- MUX $15.25
- ALDX $9.50
- AVG Volume (30 Days)
- MUX 633.2K
- ALDX 1.5M
- Earning Date
- MUX 05-07-2025
- ALDX 05-20-2025
- Dividend Yield
- MUX N/A
- ALDX N/A
- EPS Growth
- MUX N/A
- ALDX N/A
- EPS
- MUX N/A
- ALDX N/A
- Revenue
- MUX $168,945,000.00
- ALDX N/A
- Revenue This Year
- MUX $29.49
- ALDX N/A
- Revenue Next Year
- MUX N/A
- ALDX N/A
- P/E Ratio
- MUX N/A
- ALDX N/A
- Revenue Growth
- MUX N/A
- ALDX N/A
- 52 Week Low
- MUX $6.38
- ALDX $1.14
- 52 Week High
- MUX $12.50
- ALDX $7.20
- Technical
- Relative Strength Index (RSI)
- MUX 45.59
- ALDX 34.82
- Support Level
- MUX $7.25
- ALDX $1.90
- Resistance Level
- MUX $8.22
- ALDX $2.89
- Average True Range (ATR)
- MUX 0.36
- ALDX 0.23
- MACD
- MUX -0.02
- ALDX 0.10
- Stochastic Oscillator
- MUX 13.25
- ALDX 26.26
About MUX McEwen Mining Inc.
McEwen Mining Inc is a mining and minerals production and exploration company that focuses on precious and base minerals in Argentina, Mexico, and the United States. The company primarily generates its revenue from gold and silver production. It owns and operates the wholly-owned El Gallo 1 mine in Mexico and holds a minority stake in the company that manages the San Jose mine in Argentina. More than half of the company's gold output comes from the El Gallo 1 mine, while the remaining gold production and the majority of silver production are sourced from the San Jose mine. Geographically, most production occurs in the United States.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.